Dr. Cristofanilli Discusses Molecular Subtyping In Breast Cancer

Dr. Cristofanilli Discusses Molecular Subtyping in Breast Cancer

Targeted Oncology

Dr. Cristofanilli Discusses Roles of a Multidisciplinary Team in Breast Cancer

Molecular Subtyping for Breast Cancer Study

Molecular Subtyping with Breast Cancer

Dr Cristofanilli on Applications for Liquid Biopsy–Based MRD Testing in Breast Cancer

Cristofanilli Jefferson SABCS '13

Dr. Cristofanilli on Endocrine Therapy for Breast Cancer

Dr. Cristofanilli on Using CTC to Stratify Patients With Breast Cancer

Dr. Cristofanilli on the PALOMA3 Trial for Breast Cancer

Molecular Subtyping of Breast Cancer

University of Miami Health System

Overcoming Resistance in ER+ Breast Cancer

Targeted Oncology

Dr. Massimo Cristofanilli Discusses ALK Amplification in Inflammatory Breast Cancer

Molecular Testing in Breast Cancer: Will it Become Standard Practice? - Kimberly Allison, MD

Dr. Cristofanilli on the Need for Biosimilars in Oncology

Improving Survival for Advanced Breast Cancer with Massimo Cristofanilli, MD

Northwestern Univ. Feinberg School of Medicine

Next Steps Following PALOMA3 Trial for Breast Cancer

Targeted Oncology

Developments in liquid biopsy for breast cancer over 10 years

Cancer Expert talks about Precision Medicine in Breast Cancer Treatment

University of Michigan

Molecular profiling in early breast cancer

Molecular Subtyping Improves Breast Cancer Treatment

Onco'Zine - The International Oncology Network